Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dosing for prevention of postoperative chills, pain, nausea and vomiting after gallbladder surgery
IRCT20200825048515N53Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in postoperative pain, postoperative nausea and vomiting (PONV) and postanesthetic shivering (PAS), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Prevention of postoperative chills, Postoperative pain and 1 more. Started May 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20200825048515N53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N53.